Bevacizumab plus chemotherapy in metastatic colorectal cancer patients treated in clinical practice

By Rossi Luigi   Veltri Enzo   Zullo Angelo   Zoratto Federica   Colonna Maria   Di Seri Marisa   Longo Flavia   Mottolese Marcella   Giannarelli Diana   Ruco Luigi   Romiti Adriana   Barucca Viola   Adua Daniela   Tomao Silverio  

Future Oncology, Vol. 8, Iss. 9, 2012-09 ,pp. : 1193-1197

Future Medicine

Access to resources Recommend Favorite

Phase II trial of perillyl alcohol in patients with metastatic colorectal cancer

By Meadows Sherry   Mulkerin Daniel   Berlin Jordan   Bailey Howard   Kolesar Jill   Warren Deb   Thomas James  

International Journal of Gastrointestinal Cancer, Vol. 32, Iss. 2-3, 2002-12 ,pp. : 125-128

Humana Press, Inc

Access to resources Recommend Favorite

Oral Gossypol in the Treatment of Patients with Refractory Metastatic Breast Cancer: A Phase I/II Clinical Trial

By van Poznak C.  

Breast Cancer Research and Treatment, Vol. 66, Iss. 3, 2001-04 ,pp. : 239-248

Springer Publishing Company

Access to resources Recommend Favorite

Chemotherapy for metastatic breast cancer. Comparison of clinical practice and cost of drugs in two cohorts of patients: 1994–1998 and 2003–2006

By Galy Guillaume   Labidi-Galy Sana   Perol David   Bachelot Thomas   Ray-Coquard Isabelle   Tredan Olivier   Biron Pierre   Latour Jean-François   Blay Jean-Yves   Guastalla Jean-Paul   Favier Bertrand  

Breast Cancer Research and Treatment, Vol. 128, Iss. 1, 2011-07 ,pp. : 187-195

Springer Publishing Company

Access to resources Recommend Favorite

Outcome of first line systemic treatment in elderly compared to younger patients with metastatic colorectal cancer: A retrospective analysis of the CAIRO and CAIRO2 studies of the Dutch Colorectal Cancer Group (DCCG)

By Venderbosch Sabine   Doornebal Joan   Teerenstra Steven   Lemmens Wim   Punt Cornelis J. A.   Koopman Miriam  

Acta Oncologica, Vol. 51, Iss. 7, 2012-09 ,pp. : 831-839

Informa Healthcare

Access to resources Recommend Favorite